{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:43:24Z","timestamp":1792788204779,"version":"4.5.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.eururo.2026.10.007","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:14:38Z","timestamp":1792786478000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology, Risk Factors, and Prevention of Prostate Cancer"],"prefix":"10.1016","author":[{"given":"Giorgio","family":"Gandaglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam B.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalind A.","family":"Eeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Eggener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gleave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Graefen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"La Vecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mignozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4r","family":"Stattin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"van Poppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Albers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2026.10.007_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2026.10.007_b0010","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2026.10.007_b0015","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The Lancet Commission on prostate cancer: planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2026.10.007_b0020","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","article-title":"Epidemiology and prevention of prostate cancer","volume":"4","author":"Gandaglia","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2026.10.007_b0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.10.007_b0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eururo.2025.05.038","article-title":"Magnetic resonance imaging-based biopsy strategies in prostate cancer screening: a systematic review","volume":"88","author":"Schoots","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.10.007_b0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2025.10.001","article-title":"Stockholm3 versus prostate-specific antigen in prostate cancer screening: 9-year outcomes demonstrating improved detection of aggressive cancers and reduced overdiagnosis from the STHLM3 trial","volume":"89","author":"Vigneswaran","year":"2026","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.10.007_b0040","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2026.10.007_b0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nrc1781","article-title":"Predicting the future burden of cancer","volume":"6","author":"Bray","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.eururo.2026.10.007_b0050","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/jnci\/djad113","article-title":"Obesity and prostate cancer screening, incidence, and mortality in the prostate, lung, colorectal, and ovarian cancer screening trial","volume":"115","author":"Hurwitz","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2026.10.007_b0055","first-page":"1603","article-title":"The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium","volume":"26","author":"Davies","year":"2015","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.eururo.2026.10.007_b0060","unstructured":"World Cancer Research Fund\/American Institute for Cancer Research. Continuous update project report: diet, nutrition, physical activity and prostate cancer. 2014."},{"key":"10.1016\/j.eururo.2026.10.007_b0065","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41391-021-00481-7","article-title":"Obesity and biochemical recurrence in clinically localised prostate cancer: a systematic review and meta-analysis of 86,490 patients","volume":"25","author":"Rivera-Izquierdo","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2026.10.007_b0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000339","article-title":"Association between adiposity after diagnosis of prostate cancer and mortality: systematic review and meta-analysis","volume":"2","author":"Cariolou","year":"2023","journal-title":"BMJ Med"},{"key":"10.1016\/j.eururo.2026.10.007_b0075","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.2337\/dc20-0204","article-title":"Association of type 2 diabetes with cancer: a meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people","volume":"43","author":"Ling","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eururo.2026.10.007_b0080","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/ijc.24044","article-title":"Diabetes mellitus and risk of prostate cancer in the health professionals follow\u2010up study","volume":"124","author":"Kasper","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2026.10.007_b0085","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/dmrr.2582","article-title":"Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta-analysis of 11 cohort studies","volume":"31","author":"Cai","year":"2015","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.eururo.2026.10.007_b0090","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S1470-2045(25)00231-1","article-title":"Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol","volume":"26","author":"Gillessen","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2026.10.007_b0095","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1038\/s41467-026-70149-0","article-title":"The association of physical activity with urological cancer risk: a systematic review and meta-analysis","volume":"17","author":"Xie","year":"2026","journal-title":"Nat Commun"},{"key":"10.1016\/j.eururo.2026.10.007_b0100","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/annonc\/mdy073","article-title":"Physical activity in relation to risk of prostate cancer: a systematic review and meta-analysis","volume":"29","author":"Benke","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2026.10.007_b0105","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/jamaoncol.2021.3067","article-title":"Effects of exercise on cardiorespiratory fitness and biochemical progression in men with localized prostate cancer under active surveillance: the ERASE randomized clinical trial","volume":"7","author":"Kang","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eururo.2026.10.007_b0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.18332\/tid\/157231","article-title":"Cigarette smoking and prostate cancer: a systematic review and meta-analysis of prospective cohort studies","volume":"21","author":"Al-Fayez","year":"2023","journal-title":"Tob Induc Dis"},{"key":"10.1016\/j.eururo.2026.10.007_b0115","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamaoncol.2018.1071","article-title":"Association of smoking status with recurrence, metastasis, and mortality among patients with localized prostate cancer undergoing prostatectomy or radiotherapy: a systematic review and meta-analysis","volume":"4","author":"Foerster","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eururo.2026.10.007_b0120","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00394-020-02346-6","article-title":"An updated systematic review and meta-analysis on adherence to mediterranean diet and risk of cancer","volume":"60","author":"Morze","year":"2021","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.eururo.2026.10.007_b0125","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/ajcn\/nqab365","article-title":"Association of plant-based diet index with prostate cancer risk","volume":"115","author":"Loeb","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.eururo.2026.10.007_b0130","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.9053","article-title":"Plant-based diets and disease progression in men with prostate cancer","volume":"7","author":"Liu","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eururo.2026.10.007_b0135","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1017\/S0007114522002380","article-title":"The association between dairy products consumption and prostate cancer risk: a systematic review and meta-analysis","volume":"129","author":"Zhao","year":"2023","journal-title":"Br J Nutr"},{"key":"10.1016\/j.eururo.2026.10.007_b0140","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.2011.1437","article-title":"Vitamin E and the risk of prostate cancer","volume":"306","author":"Klein","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2026.10.007_b0145","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3945\/ajcn.115.114306","article-title":"Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies","volume":"102","author":"Key","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.eururo.2026.10.007_b0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1809944","article-title":"Vitamin D supplements and prevention of cancer and cardiovascular disease","volume":"380","author":"Manson","year":"2019","journal-title":"N Eng J Med"},{"key":"10.1016\/j.eururo.2026.10.007_b0155","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.25850","article-title":"Effect of vitamin D3 supplements on development of advanced cancer: a secondary analysis of the VITAL randomized clinical trial","volume":"3","author":"Chandler","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eururo.2026.10.007_b0160","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/ijerph21111532","article-title":"The association between cadmium exposure and prostate cancer: an updated systematic review and meta-analysis","volume":"21","author":"Firmani","year":"2024","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.eururo.2026.10.007_b0165","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/cncr.23695","article-title":"Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer","volume":"113","author":"Chamie","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2026.10.007_b0170","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/cncr.27941","article-title":"Agent Orange as a risk factor for high-grade prostate cancer","volume":"119","author":"Ansbaugh","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2026.10.007_b0175","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00420-023-02037-9","article-title":"Association between night work and prostate cancer: a systematic review and meta-analysis","volume":"97","author":"Jahn","year":"2024","journal-title":"Int Arch Occup Environ Health"},{"key":"10.1016\/j.eururo.2026.10.007_b0180","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5271\/sjweh.4271","article-title":"Chronotype differences in the risk of cancers, diabetes mellitus, and poor mental health among shift workers: a meta-analysis","volume":"52","author":"Li","year":"2026","journal-title":"Scand J Work Environ Health"},{"key":"10.1016\/j.eururo.2026.10.007_b0185","doi-asserted-by":"crossref","first-page":"855","DOI":"10.21873\/anticanres.17474","article-title":"Umbrella review on the relationship between vitamin D intake and cancer","volume":"45","author":"Sch\u00f6mann-Finck","year":"2025","journal-title":"Anticancer Res"},{"key":"10.1016\/j.eururo.2026.10.007_b0190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.urolonc.2024.06.002","article-title":"A systematic review of family history, race\/ethnicity, and genetic risk on prostate cancer detection and outcomes: considerations in PSA-based screening","volume":"43","author":"Graham","year":"2025","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2026.10.007_b0195","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1200\/JCO-24-02608","article-title":"Germline and somatic genomic testing for metastatic prostate cancer: ASCO guideline","volume":"43","author":"Yu","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2026.10.007_b0200","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1001\/jamaoncol.2024.2185","article-title":"BRCA1, BRCA2, and associated cancer risks and management for male patients: a review","volume":"10","author":"Cheng","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eururo.2026.10.007_b0205","doi-asserted-by":"crossref","unstructured":"Tolmeijer SH, Maurice-Dror C, Sandhu S, et al. Germline CDK12 variants in aggressive prostate cancer. Cancer Discov. In press. https:\/\/doi.org\/10.1158\/2159-8290.CD-26-0084.","DOI":"10.1158\/2159-8290.CD-26-0084"},{"key":"10.1016\/j.eururo.2026.10.007_b0210","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa1603144","article-title":"Inherited DNA-repair gene mutations in men with metastatic prostate cancer","volume":"375","author":"Pritchard","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2026.10.007_b0215","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJMoa1110000","article-title":"Germline mutations in HOXB13 and prostate-cancer risk","volume":"366","author":"Ewing","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2026.10.007_b0220","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2021.12.023","article-title":"A rare germline HOXB13 variant contributes to risk of prostate cancer in men of African ancestry","volume":"81","author":"Darst","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.10.007_b0225","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.eururo.2019.08.025","article-title":"Prostate cancer risks for male BRCA1 and BRCA2 mutation carriers: a prospective cohort study","volume":"77","author":"Nyberg","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.10.007_b0230","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.eururo.2026.01.031","article-title":"Targeted prostate cancer screening in carriers of BRCA1 or BRCA2 pathogenic germline variants detects clinically relevant disease: 5-year results from the IMPACT study","volume":"89","author":"Bancroft","year":"2026","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.10.007_b0235","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/S1470-2045(21)00522-2","article-title":"A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study","volume":"22","author":"Bancroft","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2026.10.007_b0240","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.20.00046","article-title":"Implementation of germline testing for prostate cancer: Philadelphia prostate cancer consensus conference 2019","volume":"38","author":"Giri","year":"2020","journal-title":"J Clin Onco"},{"key":"10.1016\/j.eururo.2026.10.007_b0245","unstructured":"UK National Screening Committee. UK NSC recommends prostate cancer screening for men with a BRCA2 gene change and family history of cancer. Cancer Research UK. May 28, 2026. https:\/\/news.cancerresearchuk.org\/2026\/05\/28\/uk-nsc-recommends-prostate-cancer-screening-for-men-with-a-brca2-gene-change-and-family-history-of-cancer\/."},{"key":"10.1016\/j.eururo.2026.10.007_b0250","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa2407934","article-title":"Assessment of a polygenic risk score in screening for prostate cancer","volume":"392","author":"McHugh","year":"2025","journal-title":"N Eng J Med"},{"key":"10.1016\/j.eururo.2026.10.007_b0255","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.1038\/s41467-023-43726-w","article-title":"Prostate cancer genetic risk and associated aggressive disease in men of African ancestry","volume":"14","author":"Soh","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.eururo.2026.10.007_b0260","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1038\/s41467-026-69269-4","article-title":"A catalogue of early diverged contemporary human genome variation reveals distinct Khoe-San populations","volume":"17","author":"Jaratlerdsiri","year":"2026","journal-title":"Nat Commun"},{"key":"10.1016\/j.eururo.2026.10.007_b0265","doi-asserted-by":"crossref","first-page":"8799","DOI":"10.1038\/s41467-025-63865-6","article-title":"Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry","volume":"16","author":"Gheybi","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.eururo.2026.10.007_b0270","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.eururo.2025.09.4161","article-title":"Integrating pathogenic variants, polygenic risk score, and family history for prostate cancer risk estimation in men of African ancestry","volume":"89","author":"Chen","year":"2026","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.10.007_b0275","doi-asserted-by":"crossref","DOI":"10.1200\/GO-25-00431","article-title":"Association of family history and polygenic risk scores with prostate cancer in Africa","volume":"12","author":"Odole","year":"2026","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.eururo.2026.10.007_b0280","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41391-021-00403-7","article-title":"Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24","volume":"25","author":"Karunamuni","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2026.10.007_b0285","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/jamaoncol.2023.3482","article-title":"Germline sequencing analysis to inform clinical gene panel testing for aggressive prostate cancer","volume":"9","author":"Darst","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eururo.2026.10.007_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2024.102226","article-title":"Evaluation of the prognostic role of TP53 gene mutations in prostate cancer outcome: a systematic review and meta-analysis","volume":"22","author":"Maddah","year":"2024","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.eururo.2026.10.007_b0295","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.eururo.2018.11.045","article-title":"Compound genomic alterations of TP53, PTEN, and RB1 tumor suppressors in localized and metastatic prostate cancer","volume":"76","author":"Hamid","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.10.007_b0300","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1158\/2159-8290.CD-16-0960","article-title":"Exome sequencing of African-American prostate cancer reveals loss-of-function ERF mutations","volume":"7","author":"Huang","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.eururo.2026.10.007_b0305","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMc2000069","article-title":"Racial differences in genomic profiling of prostate cancer","volume":"383","author":"Mahal","year":"2020","journal-title":"N Eng J Med"},{"key":"10.1016\/j.eururo.2026.10.007_b0310","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1056\/NEJMoa2022485","article-title":"Survival with Olaparib in metastatic castration-resistant prostate cancer","volume":"383","author":"Hussain","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2026.10.007_b0315","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.eururo.2022.05.008","article-title":"A healthy lifestyle in men at increased genetic risk for prostate cancer","volume":"83","author":"Plym","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.10.007_b0320","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.urology.2021.05.078","article-title":"Initial findings from a high genetic risk prostate cancer clinic","volume":"156","author":"Sessine","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2026.10.007_b0325","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.4_suppl.TPS357","article-title":"Prostate screening for men with inherited risk of developing aggressive prostate cancer: the PATROL study","volume":"42","author":"Cheng","year":"2024","journal-title":"J Clin Onco"},{"key":"10.1016\/j.eururo.2026.10.007_b0330","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s43018-025-01103-0","article-title":"Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study","volume":"7","author":"Vassy","year":"2026","journal-title":"Nat Cancer"},{"key":"10.1016\/j.eururo.2026.10.007_b0335","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.eururo.2024.11.013","article-title":"Recent patterns and trends in global prostate cancer incidence and mortality: an update","volume":"87","author":"Schafer","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.10.007_b0340","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/s41588-024-01931-3","article-title":"Heterogeneous genetic architectures of prostate cancer susceptibility in sub-Saharan Africa","volume":"56","author":"Janivara","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/j.eururo.2026.10.007_b0345","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.ebiom.2015.10.028","article-title":"A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men","volume":"2","author":"Petrovics","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.eururo.2026.10.007_b0350","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.44027","article-title":"Racial and ethnic disparities in prostate cancer outcomes in the Veterans Affairs Health Care System","volume":"5","author":"Yamoah","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eururo.2026.10.007_b0355","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/cncr.33224","article-title":"Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration","volume":"127","author":"McKay","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2026.10.007_b0360","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.50416","article-title":"Evaluation of social determinants of health and prostate cancer outcomes among Black and White patients","volume":"6","author":"Vince","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eururo.2026.10.007_b0365","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/jamaoncol.2019.0826","article-title":"Association of Black race with prostate cancer-specific and other-cause mortality","volume":"5","author":"Dess","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eururo.2026.10.007_b0370","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.32388","article-title":"Racial and ethnic disparities in the use of prostate magnetic resonance imaging following an elevated prostate-specific antigen test","volume":"4","author":"Abashidze","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eururo.2026.10.007_b0375","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/bju.15293","article-title":"The impact of racial residential segregation on prostate cancer diagnosis and treatment","volume":"127","author":"Poulson","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2026.10.007_b0380","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.14582","article-title":"Access to prostate-specific antigen testing and mortality among men with prostate cancer","volume":"7","author":"Iyer","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eururo.2026.10.007_b0385","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00125-004-1415-6","article-title":"Diabetes mellitus and risk of prostate cancer: a meta-analysis","volume":"47","author":"Bonovas","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.eururo.2026.10.007_b0390","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1186\/s12889-023-16085-w","article-title":"Association of cigarette smoking habits with the risk of prostate cancer: a systematic review and meta-analysis","volume":"23","author":"Yang","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.eururo.2026.10.007_b0395","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/nu10010040","article-title":"Soy consumption and the risk of prostate cancer: an updated systematic review and meta-analysis","volume":"10","author":"Applegate","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.eururo.2026.10.007_b0400","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.eururo.2025.07.017","article-title":"Dietary patterns in prostate cancer prevention and management: a systematic review of prospective cohort studies and randomized clinical trials","volume":"88","author":"Lin","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.10.007_b0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2020.110690","article-title":"PFAS and cancer, a scoping review of the epidemiologic evidence","volume":"194","author":"Steenland","year":"2021","journal-title":"Environ Res"},{"key":"10.1016\/j.eururo.2026.10.007_b0410","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.euros.2025.11.006","article-title":"Prostate cancer risk and DNA mismatch repair deficiency among lynch syndrome patients","volume":"83","author":"Rodgers-Fouch\u00e9","year":"2026","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.eururo.2026.10.007_b0415","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.eururo.2026.04.005","article-title":"Effect of prostate cancer screening with prostate-specific antigen testing on long-term prostate cancer\u2013specific mortality: a systematic review and meta-analysis of randomized controlled trials","volume":"90","author":"Nguyen","year":"2026","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.10.007_b0420","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1056\/NEJMoa2503223","article-title":"European study of prostate cancer screening \u2014 23-year follow-up","volume":"393","author":"Roobol","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2026.10.007_b0425","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.eururo.2025.06.012","article-title":"Active surveillance for screen-detected low- and intermediate-risk prostate cancer: extended follow-up up to 25 years in the G\u00d6TEBORG-1 trial","volume":"88","author":"Palmstedt","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.10.007_b0430","unstructured":"Robert koch-institut. Zentrum f\u00fcr Krebsregisterdaten. Krebs in Deutschland 2025. https:\/\/www.krebsdaten.de\/Krebs\/DE\/Content\/Publikationen\/Krebs_in_Deutschland\/krebs_in_deutschland_2025.pdf."},{"key":"10.1016\/j.eururo.2026.10.007_b0435","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1002\/cncr.33818","article-title":"Presentation, patterns of care, and outcomes of patients with prostate cancer in sub\u2010Saharan Africa: a population\u2010based registry study","volume":"127","author":"Seraphin","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2026.10.007_b0440","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0022-5347(01)62086-X","article-title":"Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants","volume":"161","author":"Cook","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2026.10.007_b0445","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/bjc.2012.486","article-title":"An inherited NBN mutation is associated with poor prognosis prostate cancer","volume":"108","author":"Cybulski","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eururo.2026.10.007_b0450","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.eururo.2024.04.030","article-title":"Risk-adjusted screening for prostate cancer-defining the low-risk group by data from the PROBASE trial","volume":"86","author":"Krilaviciute","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.10.007_b0455","article-title":"Transcriptome-wide association analysis identifies candidate susceptibility genes for prostate-specific antigen levels in men without prostate cancer","volume":"5","author":"Chen","year":"2024","journal-title":"HGG Adv"},{"key":"10.1016\/j.eururo.2026.10.007_b0460","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.eururo.2024.04.036","article-title":"Systematic review on the cost effectiveness of prostate cancer screening in Europe","volume":"86","author":"Vynckier","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.10.007_b0465","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/ijc.35513","article-title":"Cost effectiveness analysis of prostate cancer screening strategies in Germany: a microsimulation study","volume":"157","author":"Muchadeyi","year":"2025","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2026.10.007_b0470","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.eururo.2026.01.030","article-title":"Diagnostic performance of Biparametric versus multiparametric magnetic resonance imaging for prostate cancer diagnosis: an updated systematic review and meta-analysis","volume":"90","author":"Strieder de Oliveira","year":"2026","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.10.007_b0475","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.eururo.2024.09.035","article-title":"Evaluating Biparametric versus multiparametric magnetic resonance imaging for diagnosing clinically significant prostate cancer: an international, paired, noninferiority, confirmatory observer study","volume":"87","author":"Twilt","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.10.007_b0480","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.euo.2025.07.001","article-title":"Fast Biparametric versus multiparametric magnetic resonance imaging for triage of men with elevated prostate-specific antigen: the PRO-TRIAGE prospective comparative trial","volume":"9","author":"Ahn","year":"2026","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2026.10.007_b0485","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.eururo.2025.11.024","article-title":"Primary noncontrast magnetic resonance imaging for prostate cancer screening: a randomized clinical trial (PROSA)","volume":"89","author":"Messina","year":"2026","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.10.007_b0490","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2023.08.002","article-title":"Early detection of prostate cancer in the European Union: combining forces with PRAISE-U","volume":"84","author":"Van Poppel","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.10.007_b0495","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/ijc.35278","article-title":"The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide","volume":"156","author":"Filho","year":"2025","journal-title":"Int J Cancer"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283826024358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283826024358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:14:47Z","timestamp":1792786487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283826024358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":99,"alternative-id":["S0302283826024358"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2026.10.007","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology, Risk Factors, and Prevention of Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2026.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}